Work

Synthetic lethality as an engine for cancer drug target discovery

Year: 2019

Type: review

Source: Nature Reviews Drug Discovery

DOI: 10.1038/s41573-019-0046-z

Authors: Alan Huang, Levi A. Garraway, Alan Ashworth, Barbara Weber

Institutions: Tango Therapeutics (United States), Roche (United States), Eli Lilly (United States), UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: CRISPR and Genetic Engineering

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2983649157

FWCI: 4.561

Cites: 206

Cited by: 505

Related to: 10